FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4291291292> ?p ?o ?g. }

• W4291291292 endingPage "S57" @default.
• W4291291292 startingPage "S57" @default.
• W4291291292 abstract "Among novel psychoactive substances (NPS), synthetic cannabinoids (SCs) represent one of the largest subgroups. Around 2017, with the appearance of 5F-EDMB-PINACA, the ethyl analog of 5F-MDMB-PINACA (5F-ADB), the first synthetic cannabinoid carrying an ethyl ester moiety at the linked group started to circulate on the market. The unambiguous detection of the use of these substances remains challenging for forensic laboratories, especially because they tend to form common metabolites with structurally related SCs. In 2020 and 2021, further SCs with an ethyl ester moiety at the linked group emerged, among them 5F-EDMB-PICA and EDMB-PINACA, which were distributed on the German drug market. Here we present data on suitable urinary markers to prove the consumption of the ethyl ester compounds 5F-EDMB-PICA and EDMB-PINACA, facilitating differentiation from structurally similar compounds like ADB-PINACA, 5F-MDMB-PICA and 5F-EDMB-PINACA. Twenty authentic urine samples (10 for each substance) collected for abstinence control were analyzed by means of liquid chromatography time-of-flight mass spectrometry (LC-qToF-MS) after enzymatic cleavage of glucuronides. Anticipated phase I metabolites detected in authentic urine samples were confirmed in vitro by applying a pooled human liver microsomes (pHLM) assay. The prevalence of the compounds among German users between 2020 and 2022 was estimated by analyzing forensic urine samples collected for abstinence control. Ten phase I metabolites of 5F-EDMB-PICA and 18 metabolites of EDMB-PINACA were detected by LC-qToF-MS analysis of authentic human urine specimens. Not all of these metabolites could be confirmed in vitro using a pHLM assay. This was particularly seen for the products of multiple metabolic reactions. The first urine samples positive for 5F-EDMB-PICA were detected in October 2020, and for EDMB-PINACA in April 2021. From October 2020 to February 2022, a total of 1232 urine samples tested positive for SCs in the Institute of Forensic Medicine Freiburg, of which 66 (5.4%) were positive for 5F-EDMB-PICA and 125 (10.1%) for EDMB-PINACA. For both substances, the main in vivo metabolites were built by ester hydrolysis, coupled to further metabolic processes. However, these metabolites could be formed from other SCs as well and are, thus, non-specific. Investigation of phase-I biotransformation led to the identification of ester hydrolysis, defluorination and mono-hydroxylation products as the most suitable urinary biomarkers for 5F-EDMB-PICA. Suggested biomarkers for the use of EDMB-PINACA are represented by the products of ester hydrolysis coupled to ketone formation and mono-hydroxylation. Due to several common metabolites among structurally related SCs, the unequivocal detection of their consumption remains challenging for forensic laboratories and requires sensitive methods to monitor multiple targets, sometimes including minor metabolites. 5F-EDMB-PICA and EDMB-PINACA, two SCs carrying an ethyl ester moiety, peaked in 2021 and seem to have vanished afterwards from the German market." @default.
• W4291291292 created "2022-08-14" @default.
• W4291291292 creator A5004340821 @default.
• W4291291292 creator A5031625144 @default.
• W4291291292 creator A5064438405 @default.
• W4291291292 creator A5080134092 @default.
• W4291291292 creator A5087885664 @default.
• W4291291292 date "2022-09-01" @default.
• W4291291292 modified "2023-10-05" @default.
• W4291291292 title "Synthetic cannabinoids carrying an ethyl ester moiety: Human phase I metabolism and prevalence of 5F-EDMB-PICA and EDMB-PINACA" @default.
• W4291291292 doi "https://doi.org/10.1016/j.toxac.2022.06.070" @default.
• W4291291292 hasPublicationYear "2022" @default.
• W4291291292 type Work @default.
• W4291291292 citedByCount "0" @default.
• W4291291292 crossrefType "journal-article" @default.
• W4291291292 hasAuthorship W4291291292A5004340821 @default.
• W4291291292 hasAuthorship W4291291292A5031625144 @default.
• W4291291292 hasAuthorship W4291291292A5064438405 @default.
• W4291291292 hasAuthorship W4291291292A5080134092 @default.
• W4291291292 hasAuthorship W4291291292A5087885664 @default.
• W4291291292 hasConcept C170493617 @default.
• W4291291292 hasConcept C178790620 @default.
• W4291291292 hasConcept C185592680 @default.
• W4291291292 hasConcept C2776568683 @default.
• W4291291292 hasConcept C2777846614 @default.
• W4291291292 hasConcept C2780026642 @default.
• W4291291292 hasConcept C2780871563 @default.
• W4291291292 hasConcept C2994242795 @default.
• W4291291292 hasConcept C43617362 @default.
• W4291291292 hasConcept C55493867 @default.
• W4291291292 hasConceptScore W4291291292C170493617 @default.
• W4291291292 hasConceptScore W4291291292C178790620 @default.
• W4291291292 hasConceptScore W4291291292C185592680 @default.
• W4291291292 hasConceptScore W4291291292C2776568683 @default.
• W4291291292 hasConceptScore W4291291292C2777846614 @default.
• W4291291292 hasConceptScore W4291291292C2780026642 @default.
• W4291291292 hasConceptScore W4291291292C2780871563 @default.
• W4291291292 hasConceptScore W4291291292C2994242795 @default.
• W4291291292 hasConceptScore W4291291292C43617362 @default.
• W4291291292 hasConceptScore W4291291292C55493867 @default.
• W4291291292 hasIssue "3" @default.
• W4291291292 hasLocation W42912912921 @default.
• W4291291292 hasOpenAccess W4291291292 @default.
• W4291291292 hasPrimaryLocation W42912912921 @default.
• W4291291292 hasRelatedWork W1693502917 @default.
• W4291291292 hasRelatedWork W1971288108 @default.
• W4291291292 hasRelatedWork W2045060966 @default.
• W4291291292 hasRelatedWork W2108584504 @default.
• W4291291292 hasRelatedWork W2152607145 @default.
• W4291291292 hasRelatedWork W2265500971 @default.
• W4291291292 hasRelatedWork W2577402426 @default.
• W4291291292 hasRelatedWork W2951269336 @default.
• W4291291292 hasRelatedWork W2968835046 @default.
• W4291291292 hasRelatedWork W4385186437 @default.
• W4291291292 hasVolume "34" @default.
• W4291291292 isParatext "false" @default.
• W4291291292 isRetracted "false" @default.
• W4291291292 workType "article" @default.